ArticleClinical and translational medicine2025
Erratum to "CCL4-mediated targeting of spleen tyrosine kinase (Syk) inhibitor using nanoparticles alleviates inflammatory bowel disease".
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.